COMPARATIVE STUDY OF THE SYSTEMIC BIOACTIVITY OF HFA FLUTICASONE PROPIONATE VIA ANTI-STATIC SPACER DEVICES

Registry ID

EUCTR2005-005557-22

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

University of Dundee (Research & Innovation)

Start date

2006-02-17

Completion date

2007-05-29

Last update

2026-08-16

Conditions

• Bronchial Asthma

Summary

To establish whether, the systemic bioactivity of inhaled fluticasone propionate HFA formulation is comparable via the pMDI, Aerochamber® Max, Zerostat®, and Nebuchamber® devices.

Locations

• , , UK

Related clinical trials

• Evaluation of Clinical Effect of Acupuncture on Acute Exacerbation of Bronchial Asthma
• N95 Masks for Lung Health While Golfing During Wildfire Season
• Pulmonary Condensate: Non-invasive Evaluation of Pulmonary Involvement in Asthma and Cystic Fibrosis.
• Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
• Study on the Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
• Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma

View on source registry